Alkem Laboratories Limited (BOM:539523)
5,397.50
-2.50 (-0.05%)
At close: Aug 21, 2026
Alkem Laboratories Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Alkem Laboratories stock has a consensus rating of "Buy" and an average price target of ₹5,949. The average 1-year stock price forecast is 10.21% higher than the current stock price, while the lowest is ₹4,590 (-14.96%) and the highest is ₹6,850 (+26.91%).
Price Target: ₹5,949 (+10.21%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Alkem Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 6 | 6 | 7 | 7 |
| Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Hold | 7 | 7 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 3 | 3 | 4 | 4 | 4 | 4 |
| Total | 21 | 21 | 20 | 20 | 20 | 20 |
Financial Forecast
Revenue This Year
166.92B
from 147.12B
Increased by 13.46%
Revenue Next Year
185.54B
from 166.92B
Increased by 11.15%
EPS This Year
191.58
from 204.53
Decreased by -6.33%
EPS Next Year
223.84
from 191.58
Increased by 16.84%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.